Status | Study |
Recruiting |
Study Name: DNA Analysis in Samples From Younger Patients With Germ Cell Tumors and Their Parents or Siblings Condition: Childhood Malignant Ovarian Germ Cell Tumor Childhood Malignant Testicular Germ Cell Tumor Date: 2011-09-13 Interventions: Other: laboratory biomarker analysis |
Completed |
Study Name: ARQ 197 for Subjects With Relapsed or Refractory Germ Cell Tumors Condition: Non-CNS Germ Cell Tumors (Seminomas and Nonseminomas) Date: 2010-01-21 Interventions: Drug: Tivantinib (ARQ 197) Capsule, 120 mg, BID (360 mg), approximately 112 days |
Recruiting |
Study Name: PHASE II TRIAL OF THE CYCLIN-DEPEDENT KINASE INHIBITOR PD 0332991 IN PATIENTS WITH CANCER Condition: Adult Solid Tumor Adenocarcinoma of the Colon Adenocarcino Date: 2009-12-10 Interventions: Drug: PD-0332991 Given orally, |
Completed |
Study Name: Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors Condition: Recurrent Extragonadal Seminoma Recurrent Malignant Extragonada Date: 2009-08-12 Interventions: Drug: Alvocidib Hydrochloride |
Completed |
Study Name: Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients Condition: Testicular Cancer Seminoma No Date: 2008-06-23 |
Recruiting |
Study Name: Magnetic Resonance Imaging and Computed Tomography in Patients With Stage I Seminoma of the Testicle Condition: Testicular Germ Cell Tumor Date: 2007-12-25 Interventions: Other: questionnaire administration Proced |
Completed |
Study Name: Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer Condition: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia Wit Date: 2003-05-06 Interventions: Drug: ipilimumab Given IV |
Terminated |
Study Name: Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer Condition: Ovarian Dysgerminoma Recurrent Malignant Testicular Germ Cell Tumor Date: 2002-08-05 Interventions: Drug: imatinib mesylate Given |
Recruiting |
Study Name: Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma Condition: Nausea and Vomiting Testicular Germ Cell Tumor Date: 2000-01-28 Interventions: Drug: granisetron hydrochloride Drug: leri |
Completed |
Study Name: Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer Condition: Testicular Germ Cell Tumor Date: 1999-11-01 Interventions: Drug: carboplatin Radiation: radiation the |